Postpartum anestrus (PPA) condition or long PPA interval (PPAI)
(>90 days) is a reproductive problem in buffaloes. Both
genetic and non-genetic factors contribute to the variation in PPAI.
Identifying the genetic markers associated with PPA will help in the
marker-based selection of buffaloes against PPA, thereby PPA incidence
can be reduced. However, such genetic markers associated with PPA are
scanty. Therefore, the present study was targeted to identify the
association of SNPs in the gonadotropin inhibitory hormone (GnIH/NPVF)
gene with PPAI in Indian Murrah buffaloes. GnIH/NPVF is a neuropeptide
that inhibits gonadotropin-releasing hormone (GnRH) and gonadotropin
secretion. Sequencing of the GnIH/NPVF gene amplified from a pooled DNA
sample of 10 PPA and 10 healthy postpartum cyclic controls revealed 8
SNPs in the putative promoter and 5’-UTR regions. Transcription factor
binding analysis identified that the allele A of the SNP
(c.-1001A>G) at the 5’UTR region could promote the binding
of FoxO_CS transcription factor, an inhibitor of gonadotropin release.
Association analysis between the genotypes of this SNP and PPAI of 66
extreme PPA buffaloes and 83 extreme controls (PPA< 90 days)
identified its significant (P<0.0093) association with PPAI in
this selected buffalo population sample. Particularly, the G-allele of
this SNP appeared to reduce 30.33±11.51 PPAI days in Murrah buffaloes.
In conclusion, the SNP c.-1001A>G in the GnIH/NPVF gene
could be a potential genetic marker associated with PPA in Murrah
buffaloes, and this association needs further validation in large
population samples before its consideration for marker-assisted
selection programs against PPA in buffaloes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.